Ibrahim B. Dagher is Chief Medical Officer of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 0 shares of BCLI, which is worth approximately $0. The most recent transaction as insider was on Jul 19, 2024, when has been sold 63,000 shares (Common Stock) at a price of $0.35 per share, resulting in proceeds of $22,050. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

Ibrahim B. Dagher Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 19 2024
SELL
Open market or private sale
$22,050 $0.35 p/Share
63,000 Reduced 100.0%
0 Common Stock
IBD

Ibrahim B. Dagher

Chief Medical Officer
New York, NY

Track Institutional and Insider Activities on BCLI

Follow BRAINSTORM CELL THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCLI shares.

Notify only if

Insider Trading

Get notified when an Brainstorm Cell Therapeutics Inc. insider buys or sells BCLI shares.

Notify only if

News

Receive news related to BRAINSTORM CELL THERAPEUTICS INC.

Track Activities on BCLI